Several recent studies showed that simultaneous inhibition of PI3K/AKT signaling would increase apoptosis in ALL or CLL leukemia, and suppression of Erk signaling synergistically improved Nutlin-induced apoptosis in AML46. Here, AKT1 is linked to leukemia.